sodium selenate has been researched along with 3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(-)-isomer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bidlack, JM; Knapp, BI; Neumeyer, JL; Peng, X | 1 |
| Bidlack, JM; Knapp, BI; Neumeyer, JL; Scrimale, T; Sromek, A; Yan, Z; Zhang, T | 1 |
2 other study(ies) available for sodium selenate and 3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(-)-isomer
| Article | Year |
|---|---|
Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors.
Topics: Animals; CHO Cells; Cricetinae; Drug Evaluation, Preclinical; Humans; In Vitro Techniques; Ligands; Molecular Conformation; Morphinans; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Stereoisomerism; Structure-Activity Relationship | 2006 |
Aminothiazolomorphinans with mixed κ and μ opioid activity.
Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Humans; Morphinans; Radioligand Assay; Receptors, Opioid, kappa; Receptors, Opioid, mu; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 2011 |